Elevance Health
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
9% more call options, than puts
Call options by funds: $677M | Put options by funds: $619M
0.15% more ownership
Funds ownership: 88.65% [Q3] → 88.8% (+0.15%) [Q4]
7% less funds holding
Funds holding: 1,666 [Q3] → 1,557 (-109) [Q4]
26% less first-time investments, than exits
New positions opened: 205 | Existing positions closed: 276
26% less funds holding in top 10
Funds holding in top 10: 50 [Q3] → 37 (-13) [Q4]
29% less capital invested
Capital invested by funds: $106B [Q3] → $75.9B (-$30.4B) [Q4]
36% less repeat investments, than reductions
Existing positions increased: 462 | Existing positions reduced: 720
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$405
6%
downside
Avg. target
$472
9%
upside
High target
$512
19%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Argus Research David Toung 55% 1-year accuracy 6 / 11 met price target | 6%downside $405 | Hold Reiterated | 29 Jan 2025 |
Wells Fargo Stephen Baxter 33% 1-year accuracy 13 / 39 met price target | 11%upside $478 | Overweight Maintained | 28 Jan 2025 |
Cantor Fitzgerald Sarah James 33% 1-year accuracy 33 / 100 met price target | 12%upside $485 | Overweight Reiterated | 24 Jan 2025 |
Barclays Andrew Mok 44% 1-year accuracy 26 / 59 met price target | 19%upside $512 | Overweight Maintained | 24 Jan 2025 |
Truist Securities David Macdonald 61% 1-year accuracy 57 / 94 met price target | 11%upside $480 | Buy Maintained | 6 Jan 2025 |
Financial journalist opinion
Based on 6 articles about ELV published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
With a strengthening commercial business, ELV is seeing steady membership growth.
Positive
Seeking Alpha
2 weeks ago
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key factors influencing ELV's future growth and efficiency improvements.
Positive
Zacks Investment Research
2 weeks ago
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Positive
Seeking Alpha
2 weeks ago
54 Upcoming Dividend Increases, Including A King
This week features the largest list of dividend increases ever, with 50 companies, including Coca-Cola extending its 63-year streak with a 5.2% increase. My strategy focuses on companies with consistent dividend growth and outperforming benchmarks, using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ. I recommend the Schwab U.S. Dividend Equity ETF for broad U.S. equity exposure and the Cohen & Steers REIT & Preferred Income Fund for REITs.
Positive
Seeking Alpha
4 weeks ago
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last article, in this update, I give three reasons why I feel comfortable taking a contrarian position with ELV stock. Given that Elevance is in financially very healthy shape and is strongly profitable, there is obviously a large margin of safety from an operational perspective.
Negative
Seeking Alpha
4 weeks ago
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact profits.
Positive
Seeking Alpha
1 month ago
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.
Positive
Forbes
1 month ago
Elevance Health Bolsters Employer Insurance Business
Elevance Health says its acquisition of Verily's Granular Insurance Company is designed to bolster its offerings to self-funded employer clients. Financial terms of the deal aren't being disclosed, an Elevance spokeswoman said.
Neutral
CNBC
1 month ago
Alphabet's Verily to sell Granular insurance business to Elevance Health
Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 with financial backing from the commercial insurance unit of the Swiss Re Group.
Neutral
Business Wire
1 month ago
Elevance Health Foundation Announces New Five-Year, $150 Million Commitment
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announces its new five-year, $150 million commitment aimed at addressing the physical, behavioral, and social needs of under-resourced communities. Building off the Foundation's momentum from the last three years, this new strategy will strengthen its efforts to create healthier communities through an expanded multi-lever approach that includes grantmaking, impact investing, associate community engagement, and a new Community Actio.
Charts implemented using Lightweight Charts™